- Home
- TBHC vs CCEL Comparison
TBHC vs CCEL Comparison
Compare TBHC & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBHC | CCEL |
|---|---|---|
| Founded | 1966 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Managed Health Care |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.4M | 32.7M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | TBHC | CCEL |
|---|---|---|
| Price | $1.15 | $3.40 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 104.0K | 4.1K |
| Earning Date | 12-16-2025 | 10-15-2025 |
| Dividend Yield | N/A | ★ 11.63% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $409,649,000.00 | $31,747,500.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.05 | $3.19 |
| 52 Week High | $2.40 | $8.79 |
Technical Indicators
Market Signals| Indicator | TBHC | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 42.50 | 35.19 |
| Support Level | $1.14 | $3.19 |
| Resistance Level | $1.27 | $3.99 |
| Average True Range (ATR) | 0.05 | 0.23 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 35.29 | 14.18 |
Price Performance
Historical ComparisonAbout TBHC The Brand House Collective Inc.
The Brand House Collective Inc is a specialty retailer of home decor and gifts in the United States. The company stores provide various merchandise, including holiday decor, value pricing, and a stimulating in-store and online environment that provides customers with a brand experience. The company stores also offer an assortment of holiday merchandise in seasonal periods, as well as items that are suitable for gift-giving.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.